BioSpace News Archive

Sensient Technologies Corporation (NYSE: SXT) will hold its conference call to discuss 2020 second quarter results at 8:30 a.m. CDT on Friday, July 17, 2020. To participate in the conference call, contact Chorus Call Inc. at (844) 492-3726 or (412) 317-1078, and ask to join the Sensient Technologies Corporation conference call. Alternatively, the call can be accessed by using the webcast link that will be available on the Inves

In a release issued under the same headline earlier , Thursday, July 2nd, by Protara Therapeutics, Inc., please note that in the first paragraph, the amount of shares of common stock should be 25,700, not 3,700.

Hansa grants Sarepta exclusive license to develop and promote imlifidase as a potential pre-treatment prior to the administration of gene therapy in Duchenne muscular dystrophy and Limb-girdle muscular dystrophy, for patients with neutralizing antibodies to adeno-associated virus